Analytical performance of a standardized single‐platform MHC tetramer assay for the identification and enumeration of CMV‐specific CD8+ T lymphocytes
暂无分享,去创建一个
J. Gratama | P. Southwick | R. Brooimans | M. Keeney | Michael Keeney | Jan W Gratama | Rik A Brooimans | Paula C Southwick | Christopher S Boyce | Janice Popma | Dennis A Broyles | J. Popma | C. Boyce | Dennis A. Broyles
[1] P. Dellabona,et al. Use of MHC class II tetramers to investigate CD4+ T cell responses: Problems and solutions , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[2] B. van der Holt,et al. Monitoring cytomegalovirus IE‐1 and pp65‐specific CD4+ and CD8+ T‐cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations , 2008, Cytometry. Part B, Clinical cytometry.
[3] F. Brun-Vézinet,et al. Proliferative, IFNγ and IL-2-producing T-cell responses to HIV-2 in untreated HIV-2 infection , 2006, AIDS.
[4] M. Roederer,et al. Measuring Ag-specific immune responses: understanding immunopathogenesis and improving diagnostics in infectious disease, autoimmunity and cancer. , 2005, Trends in immunology.
[5] T. Schumacher,et al. MHC multimer technology: current status and future prospects. , 2005, Current opinion in immunology.
[6] C. Nugent,et al. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes. , 2005, Immunology letters.
[7] L. K. Ely,et al. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition , 2005, Nature Immunology.
[8] F. Kern,et al. Enumeration of antigen‐specific CD8+ T lymphocytes by single‐platform, HLA tetramer‐based flow cytometry: A European multicenter evaluation , 2004, Cytometry. Part B, Clinical cytometry.
[9] F. Miedema,et al. Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease. , 2003, Blood.
[10] O. Korsgren,et al. Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment , 2003, Clinical and experimental immunology.
[11] E. Remmerswaal,et al. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. , 2003, Blood.
[12] S. Rowland-Jones,et al. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. , 2002, Blood.
[13] W. Leisenring,et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. , 2002, Blood.
[14] Mark M. Davis,et al. Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients1 , 2002, Transplantation.
[15] L. Picker,et al. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. , 2002, The Journal of infectious diseases.
[16] D. Busch,et al. Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer , 2002, Nature Medicine.
[17] J. Gratama,et al. Reduction of variation in T-cell subset enumeration among 55 laboratories using single-platform, three or four-color flow cytometry based on CD45 and SSC-based gating of lymphocytes. , 2002, Cytometry.
[18] P. Klenerman,et al. Tracking T cells with tetramers: new tales from new tools , 2002, Nature Reviews Immunology.
[19] S. Grace,et al. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. , 2001, The Journal of infectious diseases.
[20] C. Tournay,et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection. , 2001, Blood.
[21] A. Meyerhans,et al. LEVELS OF VIRUS-SPECIFIC CD4 T CELLS CORRELATE WITH CYTOMEGALOVIRUS CONTROL AND PREDICT VIRUS-INDUCED DISEASE AFTER RENAL TRANSPLANTATION1 , 2001, Transplantation.
[22] C. Craddock,et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. , 2001, Blood.
[23] D. Pillay,et al. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. , 2000, Transplantation.
[24] S. Papa,et al. Reduction of intra‐ and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training , 2000, British journal of haematology.
[25] P. Griffiths,et al. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. , 1999, The Journal of infectious diseases.
[26] P. Moss,et al. Tetrameric HLA class I–minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease , 1999, Nature Medicine.
[27] F. Lacroix,et al. Impact of unified procedures as implemented in the Canadian Quality Assurance Program for T lymphocyte subset enumeration. Participating Flow Cytometry Laboratories of the Canadian Clinical Trials Network for HIV/AIDS Therapies. , 1998, Cytometry.
[28] E. Jaffee,et al. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Ogg,et al. Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.
[30] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[31] X. Jin,et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL , 1996, Journal of virology.
[32] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[33] P. Doherty,et al. Establishment and Persistence of Virus‐Specific CD4+ and CD8+ T Cell Memory , 1996, Immunological reviews.
[34] S. Riddell,et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.
[35] S. Riddell,et al. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. , 1994, Blood.
[36] G. Gahrton,et al. Cytomegalovirus viraemia and specific T‐helper cell responses as predictors of disease after allogeneic marrow transplantation , 1993, British journal of haematology.
[37] M. Boeckh,et al. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. , 1992, Blood.
[38] S. Riddell,et al. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. , 1991, Blood.
[39] William J. Britt,et al. Primary cytomegalovirus infection in pregnancy: comparison of antibody responses to virus-encoded proteins between women with and without intrauterine infection. , 1988, The Journal of infectious diseases.
[40] B. Bloom. In vitro methods in cell-mediated immunity in man. , 1971, The New England journal of medicine.
[41] J. Altman. Flow cytometry applications of MHC tetramers. , 2004, Methods in cell biology.
[42] J. Gratama,et al. Diagnostic potential of tetramer-based monitoring of cytomegalovirus-specific CD8+ T lymphocytes in allogeneic stem cell transplantation. , 2003, Clinical immunology.
[43] J. Gratama,et al. Validation of the single-platform ISHAGE method for CD34(+) hematopoietic stem and progenitor cell enumeration in an international multicenter study. , 2003, Cytotherapy.
[44] D. Pillay,et al. Characterization of CMVpp65-Specific CD81 T Lymphocytes Using MHC Tetramers in Kidney Transplant Patients and Healthy Participants. Transplantation 2000; 69: 2243. , 2000 .
[45] E. Reinherz,et al. The human T-cell receptor. , 1984, Annual review of immunology.
[46] Ozdemir,et al. Differentiation of Cytomegalovirus-specific Cd8 , 2022 .